119
Views
1
CrossRef citations to date
0
Altmetric
Liquid Chromatography

Crossed D-Optimal Experimental Design Methodology for the Chromatographic Separation of Antihypertensive Drugs

&
Pages 1070-1088 | Received 23 Jun 2014, Accepted 04 Oct 2014, Published online: 06 Jan 2015

REFERENCES

  • Abdel-Hay, M. H., T. S. Belal, E. M. Hassan, and A. A. Gazy. 2008. Derivative and derivative ratio spectrophotometric analysis of antihypertensive ternary mixture of amiloride hydrochloride, hydrochlorothiazide and timolol maleate. J. Chin. Chem. Soc. 55: 971–978.
  • Achard, J. M, G. Choukroun, A. Fournier, J. Mansour, M. Monge, R. Oprisiu, and C. Presne. 2007. Diuretic-based therapy. EMC-Nephrol. Ther. 6: 392–426.
  • Agarwal, S., A. Dwivedi, V. K. Gupta, R. Jain, and R. Mishra. 2011. Electrochemical determination of antihypertensive drug irbesartan in pharmaceuticals. Anal. Biochem. 410: 266–271.
  • Alonso, R. M., R. M. Jimenez, and I. M. Maguregui. 1998. Simultaneous detection of the b-blocker atenolol and several complementary hypertensive agents in pharmaceutical formulations and urine by capillary zone electrophoresis. J. Chromatogr. Sci. 36: 516–522.
  • Angioi, S., M. C. Gennaro, V. Gianotti, and E. Marengo. 2002. Simultaneous reversed-phase high-performance liquid chromatographic separation of mono-, di-and trichloroanilines through a gradient elution optimized by experimental design. J. Chromatogr. A. 945: 287–292.
  • Bakris, G. L., J. N. Basile, B. L. Carter, and A. H. Gradham. 2010. Combination therapy in hypertension. J. Am. Soc. Hypert. 4: 42–50.
  • Barmpalexis, P., E. Georgarakis, and F. I. Kanaze. 2009. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology. J. Pharm. Biomed. Anal. 49: 1192–1202.
  • Belal, F. F., M. S. El-Ashry, A. A. El-Emam, T. D. El-Sherbiny, H. S. Hansen, and A. M. Moustafa. 2003. Spectrophotometric determination of propranolol in formulations via oxidative coupling with 3-methylbenzothiazoline-2-one hydrazone. Il Farmaco. 58: 1179–1186.
  • Belfast, M., R. Capen, J. Gimenez, R. Lu, R. Mancinelli, M.-A. Nguyen, R. Sitrin, and J. Zhong. 2006. A practical approach to optimization and validation of a HPLC assay for analysis of polyribosyl-ribitol phosphate in complex combination vaccines. J. Chromatogr. B. 832: 208–215.
  • Carlucci, G., P. Iuliani, and A. Marrone. 2010. Investigation of the HPLC response of NSAIDs by fractional experimental design and multivariate regression analysis, response optimization and new retention parameters. J. Pharm. Biomed. Anal. 51: 46–55.
  • Dolan, J. W., J. J. Kirkland, and L. R. Snyder. 2005. Introduction to Modern Liquid Chromatography. New York, NY: Wiley & Sons. 42–54 pp.
  • Donnelly, D., S. J. Millership, and C. Parker. 2005. Ratio spectra derivative spectrophotometry for the determination of furosemide and spironolactone in a capsule formulation. Il Farmaco. 60: 333–338.
  • Douglas, P. L., R. Gheshlaghi, J. M. Scharer, and M. Moo-Young. 2008. Application of statistical design for the optimization of amino acid separation by reverse-phase HPLC. Anal. Biochem. 383: 93–102.
  • Gowrisankar, D., H. N. Shivakumar, and V. Somasekhar. 2009. Development and validation of a rapid RP-HPLC method for the determination of venlafaxine hydrochloride in pharmaceutical dosage forms using experimental design. E-J. Chem. 6: 1091–1102.
  • Greenwald, S., R. R. Lemmer, and K. G. Webster. 2003. Rapid analysis of phentolamine by high performance liquid chromatography. J. Chromatogr. Sci. 41: 57–62.
  • Gullo, A., and E. Romano. 1980. Chlorpromazine and frusemide in treatment of acute left-ventricular failure. The Lancet. 315: 1000–1002.
  • Halpin, A. H., J. M. Martin-Moreno, and M. M. Morales-Suárez-Varela. 2010. Chronic disease prevention and the New Public Health. Pub. Healt. Rev. 32: 120–154.
  • Inci, B., Y. Niyazi, A. O. Sibel, and O. Yalcin. 2000. High-performance liquid chromatographic analysis of verapamil and its application to determination in tablet dosage forms and to drug dissolution studies. Il Farmaco. 55: 376–382.
  • Kadgapathi, P., G. T. Rani, B. Satyanarayana, and D. G. Shankar. 2011. Development of a RP-HPLC for the simultaneous estimation of propranolol hydrochloride and diazepam in combined dosage form. Ind. J. Pharm. Educ. Res. 45: 296–300.
  • Kaur, K., R. Panchagnula, I. Singh, and A. Sood. 1997. Analysis of furosemide and spironolactone mixtures using first-derivative Spectrophotometry. Pharm. Sci. 3(8): 425–429.
  • Khamanga, S. M., and R. B. Walker. 2011. The use of experimental design in the development of an HPLC-ECD method for the analysis of captopril. Talanta 83: 1037–1049.
  • Kumar, D., K. S. Patel, B. A. Sandip, and A. Y. Uday. 2011. Estimation of nifedipine by reverse phase high performance liquid chromatography in tablet dosage form. Int. J. Pharm. Life Sci. 2: 610–612.
  • Lawson, A. A., and R. G. Nimmo. 1986. Parenteral chlorpromazine and frusemide: Safe and effective treatment for hypertensive emergencies. Cur. Med. Res. Opin. 10: 203–208.
  • Margaritelis, N. G., C. K. Markopoulou, and J. E. Koundourellis. 2013. Setting up the chromatographic analysis of anthelmintics using the “Crossed D-Optimal” experimental design methodology. Anal. Meth. 13: 3334–3346
  • Miller, C. J., and N. J. Miller. 1986. Statistics for Analytical Chemistry, 3rd ed. New York, NY: Wiley, 59–62 pp.
  • Mirza, S., I. Moazzam, W. I. Sayad, and A. Z. Zaheer. 2012. UV Spectrophotometric determination of minoxidil and its applications to the assay in the pharmaceutical dosages forms. D. Pharm. Chem. 4: 568–573.
  • Mishra, S. K., P. K. Panda, and S. Sahoo. 2012. HPLC Method development for simultaneous estimation of telmisartan and chlorthalidone in tablet dosage form. Int. J. Pharm. Res. Sch. 1: 1–5.
  • Montgomery, D. 1997. Design and analysis of experiments. 5th ed. London: Wiley.
  • Niveen, A. M., N. A. Noha, and A. Sameh. 2011. Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography. Talanta. 84: 666–672.
  • Parvin, M. H. 2011. Graphene paste electrode for detection of chlorpromazine. Electrochem. Commun. 13: 366–369.
  • Proceedings of the International Conference on Harmonization (ICH). 2005. Q2 (R1). Validation of Analytical procedures: Text and Methodology. US FDA Federal Register. Available at http://www.ich.org/home.html.
  • Sun, D., X. Yang, X. Xie, and H. Zhang. 2013. Sensitive and rapid determination of nifedipine using polyvinylpyrrolidone-modified carbon paste electrode. Rus. J. Elec. 49: 1–5.
  • Viskin, S., M. Berger, M. Ish-Shalom, N. Malov, M. Tamari, M. Golovner, M. Kehati, D. Zeltser, and A. Roth. 2005. Intravenous chlorpromazine for the emergency treatment of uncontrolled symptomatic hypertension in the pre-hospital setting: Data from 500 consecutive cases. I. M. A. J. 7: 812–815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.